Tuesday, February 20, 2018

Georgia Senate backs opioid and health care proposals

A proposal to create an opioid study committee and crack down on scammers who prey on addicts has sailed through the Georgia Senate.

CDC director resigns over financial conflicts of interest

Dr. Brenda Fitzgerald’s complex financial investments presented conflicts that made it difficult to do her job, according to a statement from the Department of Health and Human Services, which oversees the CDC

Deportation fears have legal immigrants avoiding health care

It remains clear that the increasingly polarized immigration debate is having a chilling effect on Hispanic participation in health care programs, particularly during the enrollment season that ended in December.

US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.

1st trial date set in state lawsuit over opioid epidemic

The first trial date has been set for a lawsuit by a state against pharmaceutical companies over the opioid epidemic.

Trump health pick wary of government drug price negotiations

President Donald Trump’s pick for health secretary said he’s wary of a broad government role in negotiating prescription drug prices, arguing that it may lead to reduced access for patients.

Trump to mandate more mental health care options for vets

Veterans Affairs Commissioner David Shulkin says officials estimate that about 20 veterans a day take their own lives.

Some lawsuits can proceed over cigarettes touted as natural

A U.S. judge in New Mexico has dismissed more than two dozen complaints against the maker of American Spirit cigarettes but is allowing others to move forward over a line of tobacco touted as natural.

Sign-ups show health law’s staying power in Trump era

A deadline burst of sign-ups after a tumultuous year for the Obama health law has revealed continued demand for the program’s subsidized individual health plans. But the Affordable Care Act’s troubles aren’t over.

A CDC ban on ‘fetus’ and ‘transgender?’ Experts alarmed

Health leaders say they are alarmed about a report that officials at the nation’s top public health agency are being told not to use certain words or phrases in official budget documents, including “fetus,” ″transgender” and “science-based.”